QL1706 Plus Anlotinib as a Later-line Treatment for Patients With Advanced Lung Cancer
Clinical trial NCT07636226 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07636226
- Sponsor
- Sun Yat-sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-30
- Primary completion
- 2028-12-30
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.